Mirae Asset Global Investments Co., Ltd. Igm Biosciences, Inc. Transaction History
Mirae Asset Global Investments Co., Ltd.
- $28 Billion
- Q2 2025
A detailed history of Mirae Asset Global Investments Co., Ltd. transactions in Igm Biosciences, Inc. stock. As of the latest transaction made, Mirae Asset Global Investments Co., Ltd. holds 1,342 shares of IGMS stock, worth $1,704. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,342
Previous 1,077
24.61%
Holding current value
$1,704
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
3 transactions
Others Institutions Holding IGMS
# of Institutions
65Shares Held
15MCall Options Held
0Put Options Held
0-
Baker Bros. Advisors LP New York, NY4.1MShares$5.2 Million0.05% of portfolio
-
Siren, L.L.C. New York, NY3.26MShares$4.13 Million0.19% of portfolio
-
Redmile Group, LLC San Francisco, CA2.95MShares$3.75 Million0.4% of portfolio
-
Black Rock Inc. New York, NY883KShares$1.12 Million0.0% of portfolio
-
Goldman Sachs Group Inc New York, NY855KShares$1.09 Million0.0% of portfolio
About IGM Biosciences, Inc.
- Ticker IGMS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 28,969,000
- Market Cap $36.8M
- Description
- IGM Biosciences, Inc., a biotechnology company, develops Immunoglobulin M (IgM) antibodies for the treatment of cancer, infectious diseases, and autoimmune and inflammatory diseases. The company's lead product candidate is IGM-2323, a bispecific IgM antibody that is in Phase 2 clinical trials to treat patients with relapsed/refractory B cell Non...